Results 301 to 310 of about 22,236,668 (323)
Some of the next articles are maybe not open access.

Treatment-related adverse events in patients with relapsed/refractory multiple myeloma.

Oncology (Williston Park, N.Y.), 2014
In the past decade we have seen four new agents approved by the US Food and Drug Administration for treatment of multiple myeloma: the proteasome inhibitor (PI) bortezomib (Velcade), the immunomodulatory agents lenalidomide (Revlimid) and thalidomide (Thalomid), and liposomal doxorubicin. These are commonly used in the treatment of relapsed/refractory (
openaire   +1 more source

Development of a new model for prediction of relevant treatment related adverse events in older individuals with gastrointestinal cancers

Journal of Geriatric Oncology
Limited tools exist to specifically predict the risk of chemotherapy toxicity and related events in older individuals with gastrointestinal (GI) cancers.We evaluated patients aged ≥60 years with GI cancers who underwent a comprehensive geriatric assessment comprising demographic, cancer variables, and geriatric domains (function, comorbidities ...
Vallish, Shenoy   +21 more
openaire   +2 more sources

Impact of treatment-related adverse events on efficacy of intralesional collagenase therapy for Peyronie’s disease

International Journal of Impotence Research, 2020
Dyvon T, Walker   +5 more
openaire   +2 more sources

[Treatment-related adverse events associated with antibody drug conjugate in breast cancer].

Bulletin du cancer
Therapeutic options for breast cancer have recently been enriched by new antibody-drug conjugates (ADC), which are now being utilized across all known molecular subtypes. ADCs represent a groundbreaking class of therapies that combine a cytotoxic agent with a monoclonal antibody via a combination molecule (linker).
Bérénice, Collineau   +3 more
openaire   +1 more source

Trends in Adverse Event Rates in Hospitalized Patients, 2010-2019

JAMA - Journal of the American Medical Association, 2022
Mark L Metersky   +2 more
exaly  

Lung Cancer Radiation May Increase the Risk of Major Adverse Cardiac Events

Ca-A Cancer Journal for Clinicians, 2019
Mike Fillon
exaly  

Home - About - Disclaimer - Privacy